April 20, 2021
CGPA Welcomes Life Sciences Investments in Federal Budget 2021, But A More Comprehensive Approach Is Needed
The Canadian Generic Pharmaceutical Association welcomes the federal government’s recognition that a stronger life sciences sector and vaccine production can contribute to a more resilient Canada and healthier Canadians. While CGPA is supportive of the proposed financial investments intended to strengthen Canada’s life sciences sector, this is only one element of what is needed to attract and sustain long-term investments.
February 22, 2021
Jean-Guy Goulet of Pharmascience Elected Chair of Canadian Generic Pharmaceutical Association ; Ray Shelley of Apotex Elected Vice-Chair
The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Mr. Jean-Guy Goulet, Chief Operating Officer of Pharmascience, as Chair of CGPA. Mr. Ray Shelley, Senior Vice President, Commercial Operations – Canada and Caribbean at Apotex Inc., has been unanimously elected as Vice-Chair of CGPA.